Hepion Pharmaceuticals, Inc. (OTC:HEPA) appeared in the 13F filings of 1 institutional investor for the quarter ended June 30, 2026.
Total holdings of HEPA shares were unchanged from Q1 2026, and the holder count was unchanged from Q2 2025.
The only institutional position in Hepion Pharmaceuticals was 1 share at the end of Q2 2026, unchanged from the prior quarter and unchanged from a year earlier.
As of June 30, 2026, the biggest holder of Hepion Pharmaceuticals was Ancora Advisors LLC with 1 share.